The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NALIRIFOX vs FOLFIRINOX vs gemcitabine plus nab-paclitaxel as first-line treatment of advanced pancreatic cancer: An individual patient data pooled analysis of phase 3 registration trials.
 
Federico Nichetti
No Relationships to Disclose
 
Simone Rota
No Relationships to Disclose
 
Eleonora Gusmaroli
No Relationships to Disclose
 
Chiara Carlotta Pircher
No Relationships to Disclose
 
Andrea Franza
No Relationships to Disclose
 
Filippo G. De Braud
Honoraria - Amgen Astellas BioPharma; BMS; Incyte; Merck; MSD; Pfizer; Roche; Sanofi; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD SERONO; Incyte; Menarini; Nerviano Medical Sciences; Nerviano Medical Sciences; Novartis Italy; Pierre Fabre; Roche; Sanofi
Research Funding - Basilea Pharmaceutical; Bayer Health; Bristol-Myers Squibb/Medarex; Daiichi Sankyo Europe GmbH; Exelixis; Ignyta; incyte; Janssen Oncology; Kymab (Inst); Loxo (Inst); MedImmune; Merck KGaA; Merck Serono (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Roche (Inst); SERVIER (Inst); Tesaro (Inst)
 
Maria Di Bartolomeo
Honoraria - BMSi; Lilly; MSD Oncology; SERVIER
Consulting or Advisory Role - Lilly; MSD Oncology
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Monica Niger
Honoraria - Accademia Nazionale Di Medicina (ACCMED); Incyte; medpoint SRL; Sandoz; SERVIER
Consulting or Advisory Role - Basilea Pharmaceutical; EMD Serono; Incyte; MSD/AstraZeneca; SERVIER; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca